Head-to-head · Cost-Efficiency Index
RX Bella vs Corsica Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
RX Bella
Someone comparing microdose against oral against injection who will get a firm figure in writing before starting.
Visit RX BellaCorsica Health
Shoppers who want compounded and brand-name GLP-1 pricing shown side by side on one platform.
Visit Corsica HealthThe verdict
RX Bella takes it, leading the Cost-Efficiency Index 67 to 66. Four routes priced from a floor on one page, a hero quoting the cheapest of them, and treatment pages that carry no price at all. Corsica Health still earns a C — Shoppers who want compounded and brand-name GLP-1 pricing shown side by side on one platform.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs RX Bella.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | RX Bella | Corsica Health |
|---|---|---|
| Cost-Efficiency Index | 67/100 | 66/100 |
| Semaglutide / mo | From $249/mo for the injection — a published floor, not a committed rate | $149/mo (starting dose, compounded) |
| Tirzepatide / mo | From $299/mo for the injection — the same floor treatment | $249/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $2,988 | $1,788 |
| Tirzepatide / yr (modeled) | $3,588 | $2,988 |
| Coverage | Nationwide telehealth, claimed but not enumerated | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #141 | #146 |
RX Bella
67/100Where the value is
- Four routes carry a figure on one page before any intake: microdose, oral, semaglutide injection and tirzepatide injection
- Nothing in the catalog is struck through — no invented "was" price and no expiring offer
- "$0 if you're not approved" is stated plainly and repeatedly
The tradeoffs
- The hero's "from $199/mo" is the microdose, not either injection
- Every figure is a floor with no dose ladder, and the eight-screen intake reaches an email gate without showing a price
Corsica Health
66/100Where the value is
- Publishes real starting dollar prices for THREE tiers on one page — compounded semaglutide, compounded tirzepatide, and brand-name Ozempic/Wegovy — a genuine transparency advantage few competitors offer at once
- Compounded semaglutide's starting price fell from $199/mo to $149/mo since a prior 2026-07-20 check — a real, verifiable decrease
- Free shipping and provider consultation included in the listed starting price
The tradeoffs
- Listed prices are floor figures for the lowest dose tier only — no published ladder for what higher, titrated doses cost
- The '15-20% average weight change' and '4.8/5 satisfaction' figures are the company's own self-reported claims, not independently sourced
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.